Skip to main content
. 2011 Oct;18(10):1673–1679. doi: 10.1128/CVI.05258-11

Table 3.

RVNA titers and percentages of protection of mice vaccinated with insect cell-expressed r-RVGa

Group Vaccine % of mice showing an RFFIT titer of >0.5 IU/ml at day postvaccination:
% protection after challenge
0 7 14 21 28 35
1 0.2 μg of solubilized r-RVG 0 50 84 84 100 100 100
2 0.3 μg of solubilized r-RVG 0 34 84 100 100 100 100
3 0.4 μg of solubilized r-RVG 0 84 84 100 100 100 100
4 50 μg of cell lysate 0 17 67 67 67 65 85
5 None (control) 0 0 0 0 0 0 0
a

Swiss albino mice in groups 1, 2, and 3 were vaccinated using the indicated solubilized fractions of r-RVG, and group 4 was vaccinated with the crude cell lysate prepared from the infected Sf-9 cell pellet. All the groups were vaccinated twice, on days 0 and 14, and challenged on day 35. Mice were bled on days 0, 7, 14, 21, 28, and 35 postvaccination. The rabies virus-neutralizing antibody (RVNA) titer was determined by the RFFIT, and the results are the percentages of mice showing RFFIT titers higher than the protective titer value (0.5 IU/ml). All the mice in experimental groups were challenged on day 35 postinfection with 30 LD50 of the rabies virus CVS strain by an intracerebral route. The percentages of protection after challenge were calculated.